These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

944 related items for PubMed ID: 11253736

  • 1. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M, Zegura B, Guzic-Salobir B, Keber I.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):113-8. PubMed ID: 11253736
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
    Rallidis LS, Megalou AA, Papageorgakis NH, Trikas AG, Chatzidimitriou GI, Tsitouris GK.
    Thromb Haemost; 1996 Sep 15; 76(3):417-21. PubMed ID: 8883280
    [Abstract] [Full Text] [Related]

  • 3. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I.
    Thromb Haemost; 1998 Nov 15; 80(5):749-56. PubMed ID: 9843166
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep 15; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 15; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 6. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 15; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 7. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.
    Obes Res; 2002 Aug 15; 10(8):717-25. PubMed ID: 12181379
    [Abstract] [Full Text] [Related]

  • 8. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
    Lundblad D, Dinesen B, Rautio A, Røder ME, Eliasson M.
    J Intern Med; 2005 Jul 15; 258(1):13-20. PubMed ID: 15953128
    [Abstract] [Full Text] [Related]

  • 9. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS, Nikfardjam M, Niessner A, Zeiner A, Jordanova N, Zorn G, Maurer G, Schreiber W, Wojta J, Huber K.
    Thromb Res; 2007 Jul 15; 119(3):331-6. PubMed ID: 16616324
    [Abstract] [Full Text] [Related]

  • 10. Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
    Kohler HP, Carter AM, Stickland MH, Grant PJ.
    Thromb Haemost; 1998 Jan 15; 79(1):14-8. PubMed ID: 9459314
    [Abstract] [Full Text] [Related]

  • 11. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G, Pannacciulli N, Coviello M, Scarangella A, Di Roma P, Caringella M, Venneri MT, Quaranta M, Giorgino R.
    Nutr Metab Cardiovasc Dis; 2008 Mar 15; 18(3):227-32. PubMed ID: 17400434
    [Abstract] [Full Text] [Related]

  • 12. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ, Harrell JS, Davenport ML.
    J Am Acad Nurse Pract; 2005 Dec 15; 17(12):535-41. PubMed ID: 16293162
    [Abstract] [Full Text] [Related]

  • 13. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 01; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
    Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G, Martignani C, Pacilli P, Boni P, Puddu P.
    Eur Heart J; 2000 Jul 01; 21(13):1081-90. PubMed ID: 10843826
    [Abstract] [Full Text] [Related]

  • 16. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ.
    Thromb Haemost; 1998 Mar 01; 79(3):587-90. PubMed ID: 9531046
    [Abstract] [Full Text] [Related]

  • 17. Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
    Väisänen S, Baumstark MW, Penttilä I, Bouchard C, Halonen P, Rankinen T, Berg A, Rauramaa R.
    Thromb Haemost; 1997 Dec 01; 78(6):1495-9. PubMed ID: 9423801
    [Abstract] [Full Text] [Related]

  • 18. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM, Barrow BA, Grant PJ, Levy JC.
    Diabetologia; 2002 May 01; 45(5):635-41. PubMed ID: 12107743
    [Abstract] [Full Text] [Related]

  • 19. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
    Ragab A, Abousamra NK, Higazy A, Saleh O.
    Lab Hematol; 2008 May 01; 14(1):1-6. PubMed ID: 18403313
    [Abstract] [Full Text] [Related]

  • 20. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT, Chaves FJ, Martínez-Usó I, García-García AB, Ascaso JF, Carmena R.
    Eur Heart J; 2001 Mar 01; 22(6):465-71. PubMed ID: 11237541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.